all-cis-5,8,11,14,17-icosapentaenoic acid/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on C-reactive protein concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“Changes in hs-CRP and BNDF values are also reported in Table 2; there were no differences between EPA and the placebo (p = 0.747 and p = 0.070, respectively).”
Quoted verbatim from High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels.. - Study
- RCT
- Participants
- 80
- Duration
- 3 months
- Dose
- 1.2 g/day EPA; the form of the EPA is not stated
- Population
- Children and adolescents aged 6 to 18 years with a DSM-5 diagnosis of attention deficit hyperactivity disorder, either drug naive or unmedicated for the previous six months, recruited at one hospital in Taiwan
High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels.2019PMID:31745072An author is affiliated with a producerPermalink
Keep reading
- Everything the graph holds on all-cis-5,8,11,14,17-icosapentaenoic acid
- Every compound studied against C-reactive protein concentration
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4542M126A595GF63X9P441R